# E5 Ethnic Factors in the Acceptability of Foreign Clinical Data - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/e5-ethnic-factors-in-the-acceptability-of-foreign-clinical-data/41b52855-1683-45c6-8857-0b5935cfedc3

> FDA guidance document: E5 Ethnic Factors in the Acceptability of Foreign Clinical Data. Issue date: June 10, 1998. Get complete insights and analysis.

---

## Details

- Title: E5 Ethnic Factors in the Acceptability of Foreign Clinical Data
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 1998-06-10
- Last Changed: 2020-04-29
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-1997-D-0360">FDA-1997-D-0360</a>

## Related Documents

- [180-Day Generic Drug Exclusivity Under the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act](https://www.globalkeysolutions.net/guidances/guidance-document/180-day-generic-drug-exclusivity-under-the-hatch-waxman-amendments-to-the-federal-food-drug-and-cosmetic-act/99b50bce-632e-41dc-871f-60d4142d9386)
- [Q5D Quality of Biotechnological/Biological Products: Derivation and Characterization of Cell Substrates Used for Production of Biotechnological/Biological Products; Availability](https://www.globalkeysolutions.net/guidances/guidance-document/q5d-quality-of-biotechnologicalbiological-products-derivation-and-characterization-of-cell-substrates-used-for-production-of-biotechnologicalbiological-products-availability/aefa81fa-3759-44d3-89fb-1df4d46b4346)
- [CVM GFI #135 Validation of Analytical Procedures for Type C Medicated Feeds](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-135-validation-of-analytical-procedures-for-type-c-medicated-feeds/c2b03161-928c-40e8-bf9e-4a3fbf218f45)